Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Cogent Biosciences (COGT) Other Non Operating Income (2017 - 2021)

Cogent Biosciences (COGT) has 4 years of Other Non Operating Income data on record, last reported at $621000.0 in Q4 2021.

  • For Q4 2021, Other Non Operating Income rose 15.0% year-over-year to $621000.0; the TTM value through Dec 2021 reached $2.5 million, up 186.64%, while the annual FY2025 figure was -$7.2 million, N/A changed from the prior year.
  • Other Non Operating Income reached $621000.0 in Q4 2021 per COGT's latest filing, roughly flat from $620000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $623000.0 in Q2 2021 and bottomed at -$10000.0 in Q4 2018.
  • Average Other Non Operating Income over 4 years is $304083.3, with a median of $201000.0 recorded in 2018.
  • The widest YoY moves for Other Non Operating Income: up 8800.0% in 2021, down 15.0% in 2021.
  • A 4-year view of Other Non Operating Income shows it stood at -$10000.0 in 2018, then soared by 920.0% to $82000.0 in 2019, then soared by 558.54% to $540000.0 in 2020, then increased by 15.0% to $621000.0 in 2021.
  • Per Business Quant database, its latest 3 readings for Other Non Operating Income were $621000.0 in Q4 2021, $620000.0 in Q3 2021, and $623000.0 in Q2 2021.